Armenia vs Fiji: Cancer death rates in children under 10 years old
Armenia
2.56 deaths per 100,000 people
in 2023
Fiji
2.61 deaths per 100,000 people
in 2012
Armenia rank
55th
Fiji rank
52nd
Cancer death rates in children under 10 years old over time
- Armenia
- Fiji
How they compare
Fiji currently reports 2.61 deaths per 100,000 people against 2.56 deaths per 100,000 people in Armenia, a difference of 0.05 deaths per 100,000 people.
The two have swapped places 2 times across 9 shared years of data; in 2001 it was Armenia ahead.
Armenia ranks 55th and Fiji ranks 52nd of 110 countries.
Across the 2 decades both report, Armenia averaged higher in 1 and Fiji in 1.
Head to head by decade
| Decade | Armenia | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.56 deaths per 100,000 people | 4.83 deaths per 100,000 people | 1.27 deaths per 100,000 people | Fiji |
| 2010s | 3.99 deaths per 100,000 people | 1.95 deaths per 100,000 people | 2.04 deaths per 100,000 people | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rates in children under 10 years old, Armenia or Fiji?
- Fiji, at 2.61 deaths per 100,000 people against 2.56 deaths per 100,000 people in Armenia as of 2012.
- What is the difference in cancer death rates in children under 10 years old between Armenia and Fiji?
- 0.05 deaths per 100,000 people, with Fiji ahead.
- How many years of comparable data are there for Armenia and Fiji?
- 9 years are reported by both, from 2001 to 2012.
- How do Armenia and Fiji rank globally for cancer death rates in children under 10 years old?
- Armenia ranks 55th and Fiji ranks 52nd of 110 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rates in children under 10 years old. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged 10-14 years.